NPI: 1750641775 · VISALIA, CA 93277 · Specialist · NPI assigned 05/23/2012
| Authorized Official | AVERY, ROBERT (CHIEF EXECUTIVE OFFICER) |
| NPI Enumeration Date | 05/23/2012 |
Other providers sharing the same authorized official: AVERY, ROBERT
| Provider | City | State | Total Paid |
|---|---|---|---|
| CALIFORNIA RETINA CONSULTANTS | BAKERSFIELD | CA | $17.53M |
| CALIFORNIA RETINA CONSULTANTS | OXNARD | CA | $3.52M |
| CALIFORNIA RETINA CONSULTANTS | SANTA MARIA | CA | $728K |
| CALIFORNIA RETINA CONSULTANTS | PALMDALE | CA | $155K |
| CALIFORNIA RETINA CONSULTANTS | SAN LUIS OBISPO | CA | $140K |
| CALIFORNIA RETINA CONSULTANTS | PASO ROBLES | CA | $93K |
| CALIFORNIA RETINA CONSULTANTS | VALENCIA | CA | $97.62 |
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 1,043 | $22K |
| 2021 | 1,139 | $82K |
| 2022 | 1,147 | $107K |
| 2023 | 1,541 | $65K |
| 2024 | 1,277 | $51K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 1,997 | 1,771 | $120K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1,004 | 989 | $104K |
| J0178 | Injection, aflibercept, 1 mg | 396 | 278 | $49K |
| 92134 | 1,799 | 1,758 | $22K | |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 130 | 85 | $15K |
| J2778 | Injection, ranibizumab, 0.1 mg | 413 | 309 | $11K |
| 92250 | 288 | 280 | $5K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 120 | 119 | $2K |